News
New AI-powered scheduling and shift swap tools make frontline workforce planning faster, fairer, and fully mobile-empowering ...
Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 156 of its Phase 3 PaTHway Trial confirming that long-term treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results